CSL Plasma is a health care startup that stands as one of the world’s largest collectors of human plasma. Committed to excellence and innovation, the company, founded in 1998 and headquartered in the United States, plays a crucial role in ensuring the well-being of tens of thousands of individuals with rare and serious diseases, enabling them to lead normal, healthy lives. Supported by its parent company CSL Behring, a global leader in plasma protein biotherapeutics, CSL Plasma operates over 280 plasma collection centers worldwide, including state-of-the-art testing laboratories and logistics centers. Its dedication to quality, safety, and community guidelines is reflected in its undivided commitment to the highest standards in plasma collection. With a remarkable heritage and a workforce of over 30,000 employees across 35 countries, CSL Plasma, as part of the CSL Group, contributes substantially to the field of medicine and human health. While the specifics of CSL Plasma's last investment are not available, its impactful presence in the healthcare industry and global reach position it as a compelling candidate for potential investment opportunities.
There is no investment information
No recent news or press coverage available for CSL Plasma.